IMM 1.19% 41.5¢ immutep limited

Following hero's recent post it is timely for us to remind...

  1. 1,770 Posts.
    Following hero's recent post it is timely for us to remind ourselves of the following:

    The FDA approval for Phase 3 has been granted as per the entry on the ClinicalTrials.gov website, date of entry January 29, 2012. The market needs to wake up and realise that the approval means that, IT MAY BE POSSIBLE THAT phase 2b is a success - otherwise we wouldn't be running with an FDA approved Phase 3 trial.

    All Good! And getting better day by day.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
41.5¢
Change
-0.005(1.19%)
Mkt cap ! $598.3M
Open High Low Value Volume
41.5¢ 41.8¢ 41.5¢ $143.4K 345.5K

Buyers (Bids)

No. Vol. Price($)
3 17837 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 179585 7
View Market Depth
Last trade - 10.23am 26/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.